BBR Partners’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.7K | Hold |
28,952
| – | – | ﹤0.01% | 235 |
|
|
2025
Q1 | $42.3K | Hold |
28,952
| – | – | ﹤0.01% | 240 |
|
|
2024
Q4 | $61.7K | Hold |
28,952
| – | – | ﹤0.01% | 243 |
|
|
2024
Q3 | $81.1K | Hold |
28,952
| – | – | 0.01% | 234 |
|
|
2024
Q2 | $67.5K | Hold |
28,952
| – | – | 0.01% | 212 |
|
|
2024
Q1 | $129K | Hold |
28,952
| – | – | 0.01% | 241 |
|
|
2023
Q4 | $92.9K | Hold |
28,952
| – | – | 0.01% | 184 |
|
|
2023
Q3 | $91.8K | Hold |
28,952
| – | – | 0.01% | 188 |
|
|
2023
Q2 | $144K | Hold |
28,952
| – | – | 0.02% | 151 |
|
|
2023
Q1 | $143K | Hold |
28,952
| – | – | 0.02% | 157 |
|
|
2022
Q4 | $182K | Hold |
28,952
| – | – | 0.02% | 165 |
|
|
2022
Q3 | $313K | Hold |
28,952
| – | – | 0.04% | 134 |
|
|
2022
Q2 | $330K | Hold |
28,952
| – | – | 0.04% | 165 |
|
|
2022
Q1 | $264K | Sell |
28,952
-35,053
| -55% | -$320K | 0.02% | 197 |
|
|
2021
Q4 | $955K | Buy |
64,005
+28,952
| +83% | +$432K | 0.11% | 83 |
|
|
2021
Q3 | $901K | Sell |
35,053
-3,955
| -10% | -$102K | 0.07% | 99 |
|
|
2021
Q2 | $1.02M | Hold |
39,008
| – | – | 0.08% | 94 |
|
|
2021
Q1 | $1.38M | Buy |
+39,008
| New | +$1.38M | 0.11% | 72 |
|